Whole-Genome Sequencing Reveals the Origin and Rapid Evolution of an Emerging Outbreak Strain of Streptococcus pneumoniae 12F

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Xianding DengDylan R Pillai

Abstract

Streptococcus pneumoniaeis a major cause of community-acquired pneumonia and septicemia in adults. The global drug-susceptible capsular serotype 12F, clonal complex 218 caused several outbreaks in the United States between 1989 and 2008, as well as a recent large outbreak in Manitoba, Canada, that resulted in 36 cases of septicemia and 3 deaths. The evolutionary origin of the Canadian outbreak strain and its relationship to the historical US outbreak strains are not known. Whole-genome deep sequencing was performed on isolates from the Canadian outbreak (n = 36), the US outbreaks (n = 9), and nonoutbreak surveys (n = 21). Phylogenomic analysis and comparative genomics were used to assess evolutionary relationships and to detect gene content differences between the isolates. The Canadian outbreak was closely related to sporadic cases that occurred preoutbreak in cross-border geographic regions in Manitoba, North Dakota, and Iowa. The emerging Canadian strain differed from US strains by acquisition of a cell-surface protein and macrolide resistance determinants via incorporation of a 5.3-kb mega cassette harboringmsrDandmefE Furthermore, during 11 months of transmission, this clone evolved rapidly and acquired fluoroquinolone res...Continue Reading

References

Sep 8, 1994·The New England Journal of Medicine·C W HogeR F Breiman
Mar 2, 1994·JAMA : the Journal of the American Medical Association·T CherianJ Dick
May 25, 2004·Antimicrobial Agents and Chemotherapy·Maria Del GrossoAnnalisa Pantosti
Nov 3, 2004·International Journal of Antimicrobial Agents·Octavian C IoachimescuPaul B Iannini
Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellUNKNOWN American Thoracic Society
Sep 15, 2009·Lancet·Katherine L O'BrienUNKNOWN Hib and Pneumococcal Global Burden of Disease Study Team
Jan 29, 2011·Science·Nicholas J CroucherStephen D Bentley
Feb 25, 2011·The New England Journal of Medicine·Jennifer L GardyPatrick Tang
Jun 2, 2011·Antimicrobial Agents and Chemotherapy·Samir N PatelUNKNOWN Canadian Bacterial Surveillance Network
Jul 29, 2011·The New England Journal of Medicine·David A RaskoMatthew K Waldor
Sep 6, 2011·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Alexey V RakovD Ashley Robinson
Aug 28, 2013·Expert Review of Anti-infective Therapy·Xianding DengDylan R Pillai
May 21, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Erin SchillbergSalaheddin M Mahmud

❮ Previous
Next ❯

Citations

May 12, 2017·Human Vaccines & Immunotherapeutics·Salaheddin M MahmudSongul Bozat-Emre
Nov 8, 2017·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Keyin LuVarun Puri
Aug 15, 2019·Implementation Science : IS·Nina Van GoethemAnnie Robert
Jul 10, 2018·The Journal of Antimicrobial Chemotherapy·Alyssa R GoldenUNKNOWN Canadian Antimicrobial Resistance Alliance (CARA)
Feb 23, 2019·PloS One·Reiko ShimbashiUNKNOWN and the Adult IPD Study Group
Jul 28, 2019·Journal of Medical Microbiology·Misako OhkusuKiyofumi Ohkusu
Sep 11, 2019·The Journal of Antimicrobial Chemotherapy·Alyssa R GoldenUNKNOWN Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
S GleichJ C Butler
© 2022 Meta ULC. All rights reserved